Colchicine prevents D-galactosamine-induced hepatitis

Area of Science:

• Hepatology
• Toxicology
• Pharmacology

Background:

• Galactosamine (GalN) intoxication is a model for studying liver damage.
• Lipoperoxidation is implicated in the pathogenesis of liver injury.

Purpose of the Study:

• To investigate the hepatoprotective effects of colchicine against galactosamine-induced liver damage in rats.
• To elucidate the role of lipoperoxidation in galactosamine toxicity.

Main Methods:

• Rats were intoxicated with galactosamine (375 mg/kg) and treated with varying doses of colchicine.
• Liver damage markers, including serum enzymes, hepatic calcium and glycogen, and lipoperoxidation (malondialdehyde), were measured.
• Plasma membrane enzyme activities were also assessed.

Main Results:

• GalN intoxication significantly increased serum liver enzymes and malondialdehyde, while decreasing plasma membrane enzyme activities.
• Colchicine pretreatment partially or almost completely prevented GalN-induced liver damage, depending on the dose.
• Colchicine's protective effect correlated with its ability to inhibit lipoperoxidation, which appeared to be an early event in GalN toxicity.

Conclusions:

• Colchicine exhibits significant hepatoprotective effects against galactosamine-induced liver injury in rats.
• Inhibition of lipoperoxidation is a key mechanism underlying colchicine's protective action.
• Lipoperoxidation may play a critical role in the development of galactosamine-induced hepatotoxicity.